(Q40679133)

22 September 2017

title

Expression of functional Fas ligand in choriocarcinoma (English)

1 reference

22 September 2017

Astrid Hammer

1

1 reference

22 September 2017

Michaele Hartmann

2

1 reference

22 September 2017

Peter Sedlmayr

3

1 reference

22 September 2017

Wolfgang Walcher

4

1 reference

22 September 2017

Gaby Kohnen

5

1 reference

22 September 2017

Gottfried Dohr

6

1 reference

22 September 2017

publication date

1 October 2002

1 reference

American Journal of Reproductive Immunology

22 September 2017

published in

1 reference

22 September 2017

volume

48

1 reference

22 September 2017

issue

4

1 reference

22 September 2017

page(s)

226-234

1 reference

Epidemiology of gestational trophoblastic disease

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2002.01119.X

Androgenetic origin of hydatidiform mole

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2002.01119.X

Expression of Fas-ligand in first trimester and term human placental villi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2002.01119.X

Lymphoid cell apoptosis induced by trophoblastic cells: a model of active foeto-placental tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2002.01119.X

The role of placental Fas ligand in maintaining immune privilege at maternal-fetal interfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2002.01119.X

Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2002.01119.X

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2002.01119.X

Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2002.01119.X

Preliminary characterization of an immunosuppressive inducer factor secreted by the JEG-3 choriocarcinoma cell line: in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2002.01119.X

Inhibitory effect of choriocarcinoma-derived high molecular weight factor (HMWF) on lymphocyte proliferation and adhesion to trophoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2002.01119.X

Epression of the Apoptosis-Inducing FAS Ligand (FASL) in Human First and Third Trimester Placenta and Choriocarcinoma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2002.01119.X

A role for CD95 ligand in preventing graft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2002.01119.X

21 January 2018

Ways around rejection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2002.01119.X

The pathology of choriocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2002.01119.X

7 January 2021

The tumor strikes back: new data on expression of the CD95(APO-1/Fas) receptor/ligand system may cause paradigm changes in our view on drug treatment and tumor immunology

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2002.01119.X

7 January 2021

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2002.01119.X

7 January 2021

Amnion epithelial cells, in contrast to trophoblast cells, express all classical HLA class I molecules together with HLA-G

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2002.01119.X

7 January 2021

Antibody reaction patterns in first trimester placenta: implications for trophoblast isolation and purity screening

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2002.01119.X

7 January 2021

Fas and Fas-ligand are expressed in the uteroplacental unit of first-trimester pregnancy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2002.01119.X

7 January 2021

Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2002.01119.X

7 January 2021

Fas-fas ligand system-induced apoptosis in human placenta and gestational trophoblastic disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2002.01119.X

7 January 2021

T-cell subsets and natural killer cell activity in patients with gestational trophoblastic neoplasia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2002.01119.X

7 January 2021

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2002.01119.X

7 January 2021

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2002.01119.X

7 January 2021

On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2002.01119.X

7 January 2021

Immunological escape mechanisms in pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2002.01119.X

7 January 2021

Decidua in human implantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2002.01119.X

7 January 2021

Absence of major histocompatibility complex antigens in choriocarcinoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2002.01119.X

7 January 2021

In vitro and in vivo immunosuppressive effects of supernatants from human choriocarcinoma cell lines

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2002.01119.X

7 January 2021

Trophoblast-derived immunoregulatory factor: demonstration of the biological function and the physicochemical characteristics of the factor derived from choriocarcinoma cell lines

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0897.2002.01119.X

7 January 2021

10.1034/J.1600-0897.2002.01119.X

Identifiers

DOI

1 reference

22 September 2017

1 reference